Taiwan Life Insurance Co (台灣人壽) is considering injecting capital into its subsidiary CTBC Insurance Co (中國信託產險), as the unit has been paying out about NT$5 million (US$168,294) per day in compensation for COVID-19 claims, parent company CTBC Financial Holding Co (中信金控) told an investors’ conference in Taipei yesterday.
The amount of the injection has not been finalized, as the number of claims affecting CTBC Insurance’s financial strength would change as the government changes its disease prevention measures, such as the isolation rules, CTBC Financial spokeswoman Chiu Ya-ling (邱雅玲) said.
The cash injection would not reduce Taiwan Life’s capital adequacy too much, Chiu said.
Photo courtesy of Taiwan Life Insurance Co
Taiwan Life’s risk-based capital (RBC) ratio stands at 335 percent and is expected to remain above 300 percent even after injecting capital into CTBC Insurance, she said.
Having sold 400,000 COVID-19 insurance policies, CTBC Insurance said that it has assigned more staff to deal with claims as domestic COVID-19 infections climb.
CTBC Financial reported that net profit in the first quarter fell 17 percent year-on-year to NT$16.29 billion, with subsidiaries CTBC Bank (中國信託銀行), CTBC Securities Co Ltd (中信證券) and Taiwan Life Insurance all reporting annual declines in net profit.
CTBC Financial’s revenue fell 0.3 percent from a year earlier, as a 16 percent increase in annual net interest income was offset by declines of 3.7 percent in annual fee income and 51 percent in annual revenue from trading, derivatives and foreign exchange.
CTBC Bank is monitoring the effects of China’s lockdowns on its business there, after the bank wrote off a loan loss of US$28 million related to a US$40 million loan to Chinese RISE Education Cayman Ltd (瑞思教育), Chiu said, adding that the bank has tightened its criteria for lending to education companies in the Chinese market.
CTBC Bank’s net interest margin edged up to 1.47 percent at the end of March, from 1.43 percent a quarter earlier, but its fee income from wealth management shrank 18 percent to NT$4.18 billion, it said.
Taiwan Life’s first-year premiums fell 28 percent year-on-year to NT$22.4 billion, because the premiums from investment-linked policies plummeted 78 percent to NT$4.9 billion from NT$22.71 billion a year earlier amid volatility in global markets, company data showed.
Assets invested by Taiwan Life totaled NT$2.02 trillion, up 0.8 percent from a quarter earlier, while the insurer invested more in equities and domestic fixed income, and reduced its weighting of mutual funds and overseas fixed income, it said.
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) would not produce its most advanced technologies in the US next year, Minister of Economic Affairs J.W. Kuo (郭智輝) said yesterday. Kuo made the comment during an appearance at the legislature, hours after the chipmaker announced that it would invest an additional US$100 billion to expand its manufacturing operations in the US. Asked by Taiwan People’s Party Legislator-at-large Chang Chi-kai (張啟楷) if TSMC would allow its most advanced technologies, the yet-to-be-released 2-nanometer and 1.6-nanometer processes, to go to the US in the near term, Kuo denied it. TSMC recently opened its first US factory, which produces 4-nanometer
PROTECTION: The investigation, which takes aim at exporters such as Canada, Germany and Brazil, came days after Trump unveiled tariff hikes on steel and aluminum products US President Donald Trump on Saturday ordered a probe into potential tariffs on lumber imports — a move threatening to stoke trade tensions — while also pushing for a domestic supply boost. Trump signed an executive order instructing US Secretary of Commerce Howard Lutnick to begin an investigation “to determine the effects on the national security of imports of timber, lumber and their derivative products.” The study might result in new tariffs being imposed, which would pile on top of existing levies. The investigation takes aim at exporters like Canada, Germany and Brazil, with White House officials earlier accusing these economies of
GREAT SUCCESS: Republican Senator Todd Young expressed surprise at Trump’s comments and said he expects the administration to keep the program running US lawmakers who helped secure billions of dollars in subsidies for domestic semiconductor manufacturing rejected US President Donald Trump’s call to revoke the 2022 CHIPS and Science Act, signaling that any repeal effort in the US Congress would fall short. US Senate Minority Leader Chuck Schumer, who negotiated the law, on Wednesday said that Trump’s demand would fail, while a top Republican proponent, US Senator Todd Young, expressed surprise at the president’s comments and said he expects the administration to keep the program running. The CHIPS Act is “essential for America leading the world in tech, leading the world in AI [artificial
REACTIONS: While most analysts were positive about TSMC’s investment, one said the US expansion could disrupt the company’s supply-demand balance Taiwan Semiconductor Manufacturing Co’s (TSMC, 台積電) new US$100 billion investment in the US would exert a positive effect on the chipmaker’s revenue in the medium term on the back of booming artificial intelligence (AI) chip demand from US chip designers, an International Data Corp (IDC) analyst said yesterday. “This is good for TSMC in terms of business expansion, as its major clients for advanced chips are US chip designers,” IDC senior semiconductor research manager Galen Zeng (曾冠瑋) said by telephone yesterday. “Besides, those US companies all consider supply chain resilience a business imperative,” Zeng said. That meant local supply would
RSS